Form 4 · MDLZ
Mondelez CEO De Put Dirk Van reports selling 129,285 shares under a 10b5-1 plan
De Put Dirk Van, Mondelez's Chief Executive Officer and a director, filed a Form 4 on Nov 6, 2026 at 6:18 PM ET reporting transactions between Nov 4, 2026 and Nov 5, 2026.
The filing reports 129,285 shares in an open-market or private sale (code S) at $68.03, about $8.8 million in total; and 129,285 shares in an exercise or conversion of a derivative security (code M).
The filing says the sales were made under a Rule 10b5-1 trading plan adopted May 15, 2026.
After these transactions, the filing lists 1,326,488 shares of Class A Common Stock held directly.
Reporting person
- De Put Dirk Van, Chief Executive Officer and a director (as filed: Van de Put Dirk)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-04 | M | Class A Common Stock | 108,386 | $43.51 | Acquired | 1,434,874 | Direct |
| 2026-11-04 | S | Class A Common Stock | 108,386 | $68.03 | Disposed | 1,326,488 | Direct |
| 2026-11-05 | M | Class A Common Stock | 20,899 | $43.51 | Acquired | 1,347,387 | Direct |
| 2026-11-05 | S | Class A Common Stock | 20,899 | $68.03 | Disposed | 1,326,488 | Direct |
| 2026-11-04 | M | Class A Common Stock (right to buy) (derivative) | 108,386 | Disposed | 20,899 | Direct | |
| 2026-11-05 | M | Class A Common Stock (right to buy) (derivative) | 20,899 | Disposed | 0 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 6, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Mondelez company file → · More Mondelez filings
Disclosures
- Editor holdings in MDLZ
- The editor holds no position in Mondelez (MDLZ). As of Nov 11, 2026.
- Last updated
- Nov 9, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold MDLZ.